Table 3.
Primary analysis: risk factors for MACE in patients with STEMI who underwent primary PCI.
| OR | 95% CI | P value | |
|---|---|---|---|
| Small increase in Scr within 48 h of hospital admission | 1.168 | 1.044–1.306 | 0.006 |
| Female | 0.858 | 0.757–0.974 | 0.017 |
| Age > 65 | 1.454 | 1.357–1.559 | <0.001 |
| History of AF | 1.591 | 1.129–2.244 | 0.008 |
| History of HF | 4.573 | 2.847–7.348 | <0.001 |
| IIb/IIIa inhibitors | 1.423 | 1.283–1.579 | <0.001 |
| ACEI/ARB | 0.887 | 0.790–0.996 | 0.043 |
| EF < 40% | 2.206 | 1.902–2.558 | <0.001 |
| Killip III-IV | 5.770 | 5.022–6.628 | <0.001 |
| SBP | 0.988 | 0.985–0.992 | <0.001 |
| HR | 1.017 | 1.014–1.020 | <0.001 |
Variables included small increase in Scr within 48 h of hospital admission, sex, age > 65, hypertension, diabetes, history of AF, history of heart failure, use of glycoprotein IIb/IIIa inhibitors, use of ACEI/ARB, use of beta-blockers, EF < 40%, Killip III-IV, SBP, HR, and previous MI.